UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 14, 2026 5:00 P.M.
Form:
S-1
CIK:
0001847345
Company Name:
Aspire Biopharma Holdings, Inc.
File Number:
333-293515